Search - tctmd.com

Displaying 941 - 960 of 962

Sort: Relevancy | Date

News Daily News

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

Jason Kahn

April 18, 2011

News Daily News

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

Leah Lawrence

April 11, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Industry News

Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization

April 07, 2011

News Conference News

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

Jason Kahn

April 05, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

April 04, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

News Conference News

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Caitlin E. Cox

April 03, 2011

News Industry News

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

April 03, 2011

News Industry News

Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC

April 03, 2011

News Daily News

ESC: Newer Risk Scores May Be Needed for Predicting Mortality in Valve Disease

L.A. McKeown

March 18, 2011

News Industry News

Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve

February 23, 2011

News Industry News

SCAI Announces its Inaugural Class of Emerging Leader Mentorship Fellows

February 06, 2011

News Industry News

Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan

January 18, 2011

News Daily News

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

L.A. McKeown

January 13, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

Caitlin E. Cox

January 11, 2011

News Daily News

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

January 11, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

January 04, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

Advertisement

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

PARTNER: TAVI Cost Effective Compared With Standard Care

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC

ESC: Newer Risk Scores May Be Needed for Predicting Mortality in Valve Disease

Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve

SCAI Announces its Inaugural Class of Emerging Leader Mentorship Fellows

Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

NEJM Letters Take on PARTNER Trial

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content